683 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

TALS

Talaris Therapeutics
US$27.20-4.9%91.5%US$553.2mUS$200.00PB3.7xn/an/a

KDNY

Chinook Therapeutics
US$40.390.3%95.7%US$2.9bUS$40.09PS495.8xE22.6%n/a

EQRX

EQRx
US$2.34-5.3%-36.2%US$1.1bn/aPB1xS123.3%n/a

YMTX

Yumanity Therapeutics
US$13.23-8.3%-41.3%US$143.6mn/aPS29.7xn/an/a

GRPH

Graphite Bio
US$22.26539.7%861.6%US$190.4mn/aPB7.1xE36.4%n/a

NGM

NGM Biopharmaceuticals
US$1.54-3.1%-59.8%US$128.5mUS$1.55PS29.1xE14.7%n/a

MNPR

Monopar Therapeutics
US$0.65-14.6%-23.6%US$11.8mUS$2.08PB1.5xE19.8%n/a

VNDA

Vanda Pharmaceuticals
US$5.13-6.4%-16.6%US$293.9mUS$5.21PS1.7xE30.9%n/a

ABEO

Abeona Therapeutics
US$4.20-7.9%38.6%US$117.6mUS$19.50PS32.8xE53.6%n/a

SGMT

Sagimet Biosciences
US$4.381.2%n/aUS$135.3mUS$40.00PS69.9xE-26.1%n/a

MEIP

MEI Pharma
US$3.161.0%-57.7%US$20.8mUS$22.67PE0.8xE-51.0%n/a

SPRY

ARS Pharmaceuticals
US$8.98-5.2%9.9%US$861.4mUS$19.00PS87011.9xE56.3%n/a

ATOS

Atossa Therapeutics
US$1.54-9.4%116.0%US$183.6mUS$4.67PB2.3xE73.0%n/a

TARA

Protara Therapeutics
US$3.3416.4%-4.3%US$66.7mUS$27.80PB1.2xE0.5%n/a

MGNX

MacroGenics
US$4.45-72.3%-26.7%US$274.3mUS$14.00PS6.4xE-18.6%n/a

CDXC

ChromaDex
US$3.66-2.4%144.0%US$255.2mUS$6.34PS3.3xE96.7%n/a

BBLG

Bone Biologics
US$2.3030.7%-95.0%US$1.7mUS$19.50PB0.7xE0.5%n/a

CAPR

Capricor Therapeutics
US$5.20-4.8%22.6%US$171.4mUS$21.25PS6xE54.9%n/a

TNYA

Tenaya Therapeutics
US$4.40-4.6%-34.6%US$336.1mUS$19.43PB2.5xE53.0%n/a

VTYX

Ventyx Biosciences
US$4.17-9.4%-87.8%US$290.4mUS$10.70PB1xE23.6%n/a

RNXT

RenovoRx
US$1.4511.6%-34.3%US$33.8mUS$3.75PB19.7xE65.8%n/a

FRTX

Fresh Tracks Therapeutics
US$0.911.1%78.4%US$5.4mn/aPB0.5xn/an/a

GHRS

GH Research
US$13.027.8%24.0%US$670.1mUS$32.00PB3.1xE-17.9%n/a

NRIX

Nurix Therapeutics
US$14.955.6%52.1%US$826.9mUS$25.09PS11xE-4.1%n/a
Page 1 of 29
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.